International Ombudsman Association – Trademark Portfolio
Entity Type: 99
International Ombudsman Association owns a portfolio of 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CO-OP, INTERNATIONAL OMBUDSMAN ASSOCIATION, CERTIFIED ORGANIZATIONAL OMBUDSMAN PRACTITIONER, and CO-OP CERTIFIED ORGANIZATIONAL OMBUDSMAN PRACTITIONER. Of these, 4 are registered. The portfolio spans 1 Nice Classification class, led by Class 35 (Advertising & Business). Headquartered in Seattle, WA.
Seattle, WA 98133
Showing of trademarks Trademarks
Trademark Classifications
International Ombudsman Association's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does International Ombudsman Association have?
International Ombudsman Association has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does International Ombudsman Association file in?
International Ombudsman Association files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.
What are International Ombudsman Association's most well-known trademarks?
International Ombudsman Association's registered trademark portfolio includes well-known marks such as CO-OP, INTERNATIONAL OMBUDSMAN ASSOCIATION, CERTIFIED ORGANIZATIONAL OMBUDSMAN PRACTITIONER, and CO-OP CERTIFIED ORGANIZATIONAL OMBUDSMAN PRACTITIONER. These are among 4 currently registered trademarks in the portfolio.
What is International Ombudsman Association's trademark registration success rate?
International Ombudsman Association has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.